In 2025, the gold standard of ADHD diagnosis and treatment is evolving, shaped by updated DSM-5 criteria, new…
Blog
- All articles
- News
- ADHD Research and Evidence
- Clinical Practice
- Clinician Guides
- Community
- Events
- Expert Q&A
- Guest Blogs
CHIRP model’s objective technology (QbCheck) improves ADHD care efficiency in New Zealand (2023)
QbCheck’s objective ADHD testing solutions land in New Zealand. The CHIRP model (combining paediatrics, child development services and…
What is the future of ADHD care? Recap of the 2025 ADHD Expert Consortium meeting
Each year, the ADHD Expert Consortium meets to review progress and identify new strategies to address gaps in…
Navigating prescribing restrictions for ADHD medication: Strategies for US clinics
In the US, strict and ever-changing prescribing rules, medication shortages, and increased scrutiny on controlled substances prescribed…
The future of ADHD research: Emerging trends for 2025
2025 promises further advancements that will continue to shape ADHD diagnosis, treatment, and support for practitioners as well…
Vorteile und Herausforderungen von ADHS-Ferntests in Deutschland
Bei der Diagnose von ADHS in Deutschland muss man sich in einem umfassenden und manchmal komplexen medizinischen System…
How women’s health and hormones affect ADHD: Expert clinician webinar
In recent years, there has been growing awareness of how ADHD uniquely affects women across their lifespan, particularly…
QbTest is the first digital technology recommended by NICE to assess ADHD
QbTest has officially been evaluated and recommended within the National Institute of Health and Care Excellence (NICE) Diagnostics…
QbAccess: Affordable ADHD solutions for non-profit clinics by Qbtech
As a part of our commitment to improve the lives of people with ADHD, we’ve recently launched QbAccess,…
How important is the QbTest Behavior Observation Form?
Gill Wales, a clinical advisor here at Qbtech, first came across QbTest when she worked as a nurse…
